Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Genes, erbB-2

abstract

  • Weekly trastuzumab and paclitaxel therapy is active in women with metastatic breast cancer. Therapy was relatively well tolerated; however, attention to cardiac function is necessary.

publication date

  • May 15, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11352950

Additional Document Info

start page

  • 2587

end page

  • 95

volume

  • 19

number

  • 10